Breast Cancer Coverage from Every Angle
Advertisement
Advertisement

Anthony D. Elias, MD, on Balancing Treatment and Quality of Life

Posted: Friday, March 23, 2018

How do you discuss diarrhea with patients who have HER2-positive early breast cancer and are starting neratinib as a risk-reducing strategy?



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.